These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 24911517

  • 1. Synergy of combined tPA-edaravone therapy in experimental thrombotic stroke.
    Sun YY, Morozov YM, Yang D, Li Y, Dunn RS, Rakic P, Chan PH, Abe K, Lindquist DM, Kuan CY.
    PLoS One; 2014; 9(6):e98807. PubMed ID: 24911517
    [Abstract] [Full Text] [Related]

  • 2. Prophylactic Edaravone Prevents Transient Hypoxic-Ischemic Brain Injury: Implications for Perioperative Neuroprotection.
    Sun YY, Li Y, Wali B, Li Y, Lee J, Heinmiller A, Abe K, Stein DG, Mao H, Sayeed I, Kuan CY.
    Stroke; 2015 Jul; 46(7):1947-55. PubMed ID: 26060244
    [Abstract] [Full Text] [Related]

  • 3. Extension of ischemic therapeutic time window by a free radical scavenger, Edaravone, reperfused with tPA in rat brain.
    Zhang W, Sato K, Hayashi T, Omori N, Nagano I, Kato S, Horiuchi S, Abe K.
    Neurol Res; 2004 Apr; 26(3):342-8. PubMed ID: 15142331
    [Abstract] [Full Text] [Related]

  • 4. A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia.
    Sun YY, Kuan CY.
    J Vis Exp; 2015 Aug 18; (102):e52978. PubMed ID: 26325524
    [Abstract] [Full Text] [Related]

  • 5. The lipophilic multifunctional antioxidant edaravone (radicut) improves behavior following embolic strokes in rabbits: a combination therapy study with tissue plasminogen activator.
    Lapchak PA, Zivin JA.
    Exp Neurol; 2009 Jan 18; 215(1):95-100. PubMed ID: 18851964
    [Abstract] [Full Text] [Related]

  • 6. Edaravone with and without .6 Mg/Kg Alteplase within 4.5 Hours after Ischemic Stroke: A Prospective Cohort Study (PROTECT4.5).
    Yamaguchi T, Awano H, Matsuda H, Tanahashi N, PROTECT4.5 Investigators.
    J Stroke Cerebrovasc Dis; 2017 Apr 18; 26(4):756-765. PubMed ID: 27887792
    [Abstract] [Full Text] [Related]

  • 7. Effects of edaravone, a free radical scavenger, on circulating levels of MMP-9 and hemorrhagic transformation in patients with intravenous thrombolysis using low-dose alteplase.
    Tsuruoka A, Atsumi C, Mizukami H, Imai T, Hagiwara Y, Hasegawa Y.
    J Stroke Cerebrovasc Dis; 2014 Apr 18; 23(10):2894-2899. PubMed ID: 25282183
    [Abstract] [Full Text] [Related]

  • 8. Attenuation of extravasation of tissue plasminogen activator by the free radical scavenger, edaravone: evaluation in a rat thromboembolic stroke model.
    Kano T, Harada T, Katayama Y.
    Neurol Res; 2005 Jul 18; 27(5):499-502. PubMed ID: 15978175
    [Abstract] [Full Text] [Related]

  • 9. Modifying neurorepair and neuroregenerative factors with tPA and edaravone after transient middle cerebral artery occlusion in rat brain.
    Deguchi K, Miyazaki K, Tian F, Liu N, Liu W, Kawai H, Omote Y, Kono S, Yunoki T, Deguchi S, Abe K.
    Brain Res; 2012 Feb 03; 1436():168-77. PubMed ID: 22221736
    [Abstract] [Full Text] [Related]

  • 10. Edaravone, a free radical scavenger, inhibits MMP-9-related brain hemorrhage in rats treated with tissue plasminogen activator.
    Yagi K, Kitazato KT, Uno M, Tada Y, Kinouchi T, Shimada K, Nagahiro S.
    Stroke; 2009 Feb 03; 40(2):626-31. PubMed ID: 19095969
    [Abstract] [Full Text] [Related]

  • 11. Sickle Mice Are Sensitive to Hypoxia/Ischemia-Induced Stroke but Respond to Tissue-Type Plasminogen Activator Treatment.
    Sun YY, Lee J, Huang H, Wagner MB, Joiner CH, Archer DR, Kuan CY.
    Stroke; 2017 Dec 03; 48(12):3347-3355. PubMed ID: 29127268
    [Abstract] [Full Text] [Related]

  • 12. Toll-Like Receptor 4 Mediates Hemorrhagic Transformation After Delayed Tissue Plasminogen Activator Administration in In Situ Thromboembolic Stroke.
    García-Culebras A, Palma-Tortosa S, Moraga A, García-Yébenes I, Durán-Laforet V, Cuartero MI, de la Parra J, Barrios-Muñoz AL, Díaz-Guzmán J, Pradillo JM, Moro MA, Lizasoain I.
    Stroke; 2017 Jun 03; 48(6):1695-1699. PubMed ID: 28428349
    [Abstract] [Full Text] [Related]

  • 13. Opening the window: Ischemic postconditioning reduces the hyperemic response of delayed tissue plasminogen activator and extends its therapeutic time window in an embolic stroke model.
    Esmaeeli-Nadimi A, Kennedy D, Allahtavakoli M.
    Eur J Pharmacol; 2015 Oct 05; 764():55-62. PubMed ID: 26123846
    [Abstract] [Full Text] [Related]

  • 14. Pericyte protection by edaravone after tissue plasminogen activator treatment in rat cerebral ischemia.
    Deguchi K, Liu N, Liu W, Omote Y, Kono S, Yunoki T, Deguchi S, Yamashita T, Ikeda Y, Abe K.
    J Neurosci Res; 2014 Nov 05; 92(11):1509-19. PubMed ID: 24938625
    [Abstract] [Full Text] [Related]

  • 15. [Therapeutic time window for ischemic stroke].
    Abe K.
    Rinsho Shinkeigaku; 2011 Nov 05; 51(11):1182-4. PubMed ID: 22277527
    [Abstract] [Full Text] [Related]

  • 16. Outcome of Acute Ischemic Stroke after the Treatment with Edaravone and 0.6 Mg/Kg Alteplase in Japanese Patients with Diabetes.
    Tanahashi N, Yamaguchi T, Awano H, Matsuda H.
    J Stroke Cerebrovasc Dis; 2018 May 05; 27(5):1302-1310. PubMed ID: 29373227
    [Abstract] [Full Text] [Related]

  • 17. Intravenous thrombolysis with neuroprotective therapy by edaravone for ischemic stroke patients older than 80 years of age.
    Kono S, Deguchi K, Morimoto N, Kurata T, Yamashita T, Ikeda Y, Narai H, Manabe Y, Takao Y, Kawada S, Kashihara K, Takehisa Y, Inoue S, Kiriyama H, Abe K.
    J Stroke Cerebrovasc Dis; 2013 Oct 05; 22(7):1175-83. PubMed ID: 23507462
    [Abstract] [Full Text] [Related]

  • 18. Simultaneous administration of recombinant tissue plasminogen activator and edaravone in acute cerebral ischemic stroke patients.
    Takenaka K, Kato M, Yamauti K, Hayashi K.
    J Stroke Cerebrovasc Dis; 2014 Oct 05; 23(10):2748-2752. PubMed ID: 25307430
    [Abstract] [Full Text] [Related]

  • 19. UPEI-300, a conjugate of lipoic acid and edaravone, mediates neuroprotection in ischemia/reperfusion.
    Connell BJ, Saleh MC, Kucukkaya I, Abd-El-Aziz AS, Khan BV, Saleh TM.
    Neurosci Lett; 2014 Feb 21; 561():151-5. PubMed ID: 24394910
    [Abstract] [Full Text] [Related]

  • 20. The synergetic effect of edaravone and borneol in the rat model of ischemic stroke.
    Wu HY, Tang Y, Gao LY, Sun WX, Hua Y, Yang SB, Zhang ZP, Liao GY, Zhou QG, Luo CX, Zhu DY.
    Eur J Pharmacol; 2014 Oct 05; 740():522-31. PubMed ID: 24975100
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.